Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

Phase 4

3(50.0%)

N/A

2(33.3%)

Phase 1

1(16.7%)

6Total

Phase 4(3)

N/A(2)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT01115465Not ApplicableUnknown

Study of Macroplastique Safety and Effectiveness in the Treatment of Female Stress Urinary Incontinence

Role: lead

NCT01666405Phase 1Terminated

Prospective, Multicenter Trial to Investigate the Safety and Efficacy of Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence

Role: lead

NCT00928395Phase 4Completed

Modified Extension Study to the SUmiT Trial: Evaluation of Long Term Therapy With Percutaneous Tibial Nerve Stimulation (PTNS) for Overactive Bladder Symptoms

Role: lead

NCT00448175Phase 4Completed

Overactive Bladder Innovative Therapy Trial (OrBIT)

Role: lead

NCT00771264Phase 4Completed

Study of Urgent PC Versus Sham Effectiveness in Treatment of Overactive Bladder Symptoms

Role: lead

NCT00530933Not ApplicableUnknown

Tibial Nerve Stimulation for Faecal Incontinence

Role: collaborator

All 6 trials loaded